Skip to main content
Article thumbnail
Location of Repository

Apolipoprotein C3 Polymorphisms, Cognitive Function and Diabetes in Caribbean Origin Hispanics

By Caren E. Smith, Katherine L. Tucker, Tammy M. Scott, Maria Van Rompay, Josiemer Mattei, Chao-Qiang Lai, Laurence D. Parnell, Mireia Junyent, Yu-Chi Lee, Bibiana Garcia-Bailo and José M. Ordovás
Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:2674932
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2006). A genotype of exceptional longevity is associated with preservation of cognitive function.
    2. (2008). A test for genetic association that incorporates information about deviation from Hardy-Weinberg proportions in cases.
    3. (2006). Apolipoprotein CIII induces expression of vascular cell adhesion molecule-1 in vascular endothelial cells and increases adhesion of monocytic cells.
    4. (1995). Apolipoprotein E alleles but neither apolipoprotein B nor apolipoprotein AI/ CIII alleles are associated with late onset, familial Alzheimer’s disease.
    5. (1997). Association between genetic variations of apo AI-CIII-AIV cluster gene and hypertriglyceridemic subjects.
    6. (2007). Association between the -455T.C promoter polymorphism of the APOC3 gene and the metabolic syndrome in a multi-ethnic sample.
    7. (2007). Associations of the apolipoprotein A1/C3/A4/A5 gene cluster with triglyceride and HDL cholesterol levels in women with type 2 diabetes. Atherosclerosis
    8. (1991). Cause-specific mortality in a populationbased study of diabetes.
    9. (1995). Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia.
    10. (2005). Comparison of three methods to estimate genetic ancestry and control for stratification in genetic association studies among admixed populations.
    11. (1991). Estimation of HardyWeinberg and pairwise disequilibrium in the apolipoprotein AI-CIII-AIV gene cluster.
    12. (2004). Foxo1 mediates insulin action on apoC-III and triglyceride metabolism.
    13. (2001). Genetic heterogeneity in the apolipoprotein C-III promoter and effects of insulin.
    14. (2006). Genetics of Asthma in Latino Americans GALA Study. Population stratification confounds genetic association studies among Latinos.
    15. (2005). Haploview: analysis and visualization of LD and haplotype maps.
    16. (2003). Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies.
    17. (1997). Interaction between obesity and genetic polymorphisms in the apolipoprotein CIII gene and lipoprotein lipase gene on the risk of hypertriglyceridemia in Chinese.
    18. LaiCQ,ParnellLD,OrdovasJM(2005)TheAPOA1/C3/A4/A5genecluster,lipid metabolism and cardiovascular disease risk.
    19. (2006). Lipoprotein genotype and conserved pathway for exceptional longevity in humans.
    20. (2006). Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study.
    21. (2001). Low insulin resistance and preserved beta-cell function contribute to human longevity but are not associated with TH-INS genes.
    22. (2007). Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes.
    23. (2001). Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study.
    24. (1985). Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III.
    25. (2003). Nutritional and hormonal factors control the gene expression of FoxOs, the mammalian homologues of DAF-16.
    26. (2002). Plasma HDL levels highly correlate with cognitive function in exceptional longevity.
    27. (2009). Population admixture associated with disease prevalence in the Boston Puerto Rican health study.
    28. (2004). Preservation of cognitive and functional ability as markers of longevity.
    29. (1989). Reducing hypertriglyceridemia in elderly patients with cerebrovascular disease stabilizes or improves cognition and cerebral perfusion.
    30. (1991). Restriction fragment length polymorphisms of the apolipoprotein A-I, C-III, A-IV gene locus. Relationships with lipids, apolipoproteins, and premature coronary artery disease.
    31. (1993). Statistical tests of neutrality of mutations.
    32. (2008). Synergistic effects of the apolipoprotein E epsilon3/epsilon2/epsilon4, the cholesteryl ester transfer protein TaqIB, and the apolipoprotein C3 -482 C.T polymorphisms on their association with coronary artery disease. Atherosclerosis
    33. (2005). The APOC3 SstI polymorphism is weakly associated with sporadic Alzheimer’s disease in a Chinese population.
    34. (2006). The contribution of individual and pairwise combinations of SNPs in the APOA1 and APOC3 genes to interindividual HDL-C variability.
    35. (1999). The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons.
    36. WaterworthDM,TalmudPJ,HumphriesSE,WicksPD,SagnellaGA,etal.(2001) VariableeffectsoftheAPOC3-482C.Tvariantoninsulin,glucoseandtriglyceride concentrations in different ethnic groups.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.